Literature DB >> 6332694

Raised IgE levels in beta-thalassaemia: correlation with splenectomy and hepatitis B virus infection.

A Vierucci, M de Martino, M E Rossi, C Vullo, L Borgatti, W T London, B S Blumberg.   

Abstract

IgE values obtained in 117 beta-thalassaemia patients were significantly higher than in age matched normal subjects. In 31 patients (26.5%) IgE levels were above 2 s.d. of normal values for age, but the frequency of IgE with reaginic activity was lower in patients (5.1%) than in controls (11.9%). The highest values were observed in splenectomized patients who were also positive for one or more serological markers of hepatitis B virus infection. The increase of IgE levels was directly correlated with the number of years after splenectomy, and patients with biopsy proven chronic liver disease had higher IgE levels than those without evidence of liver damage. On the other hand, IgE levels were not correlated with the number of transfusions, age, IgG, IgA, IgM levels or T cell subsets and mitogen responsiveness. These results show that beta-thalassaemia patients develop elevated IgE levels to which splenectomy and hepatitis B virus infection contribute in a synergistic manner.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6332694      PMCID: PMC1576967     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  24 in total

1.  Serum IgE levels in patients with liver disease.

Authors:  R A Joske; K J Turner; B P Murphy
Journal:  Med J Aust       Date:  1976-10-09       Impact factor: 7.738

2.  Elevated levels of gamma-E (IgE) in conditions other than classical allergy.

Authors:  D C Heiner; B Rose
Journal:  J Allergy       Date:  1970-01

3.  Raised serum levels of IgE in infectious mononucleosis.

Authors:  F Nordbring; S G Johansson; A Espmark
Journal:  Scand J Infect Dis       Date:  1972

4.  NBT test in thalassemia.

Authors:  P A Tovo; R Miniero; A Ponzone
Journal:  J Pediatr       Date:  1977-04       Impact factor: 4.406

5.  Serum immunoglobulin levels in Australia antigen positive and Australia antigen negative hepatitis.

Authors:  C J Peters; K M Johnson
Journal:  Clin Exp Immunol       Date:  1972-07       Impact factor: 4.330

6.  Australia antigen and antibody in transfused children with thalassaemia.

Authors:  A Vierucci; W T London; B S Blumberg; A I Sutnick; F Ragazzini
Journal:  Arch Dis Child       Date:  1972-10       Impact factor: 3.791

7.  Depression of grass pollen-induced lymphocyte transformation by serum from hyposensitized patients.

Authors:  S Romagnani; G Biliotti; M Ricci
Journal:  Clin Exp Immunol       Date:  1975-01       Impact factor: 4.330

8.  Usefulness of monoclonal antibodies in the diagnosis and monitoring of patients with primary immunodeficiencies: combined experience in three clinical immunology centers.

Authors:  F Aiuti; I Quinti; R Seminara; M C Sirianni; A Vierucci; T Abo; M D Cooper
Journal:  Diagn Immunol       Date:  1983

9.  An immunoradiometric assay for ferritin in the serum of normal subjects and patients with iron deficiency and iron overload.

Authors:  G M Addison; M R Beamish; C N Hales; M Hodgkins; A Jacobs; P Llewellin
Journal:  J Clin Pathol       Date:  1972-04       Impact factor: 3.411

10.  Surface markers on human T and B lymphocytes. I. A large population of lymphocytes forming nonimmune rosettes with sheep red blood cells.

Authors:  M Jondal; G Holm; H Wigzell
Journal:  J Exp Med       Date:  1972-08-01       Impact factor: 14.307

View more
  3 in total

1.  Interference of hepatitis B virus surface antigen with natural killer cell function.

Authors:  M de Martino; M E Rossi; A T Muccioli; M Resti; A Vierucci
Journal:  Clin Exp Immunol       Date:  1985-07       Impact factor: 4.330

2.  Increased total serum IgE concentration in patients who have undergone splenectomy after trauma.

Authors:  G Chelazzi; G Pinotti; C Nicora; D Rossi; G Senaldi
Journal:  J Clin Pathol       Date:  1985-11       Impact factor: 3.411

3.  Abnormalities in the immune system of children with beta-thalassaemia major.

Authors:  J Dwyer; C Wood; J McNamara; A Williams; W Andiman; L Rink; T O'Connor; H Pearson
Journal:  Clin Exp Immunol       Date:  1987-06       Impact factor: 4.330

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.